Form 4 for EQH Equitable Holdings, Inc.
Accepted 2024-02-02 00:00:00 ET · period of report 2024-02-01 · accession 0000950170-24-010589 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-02-02 | 2024-02-01 | EQH | Pearson Mark | Pres, CEO, Dir | M - OptEx | $20.04 | +40.0K | 679.6K | +6% | +$801.7K |
| DMT | 2024-02-02 | 2024-02-01 | EQH | Pearson Mark | Pres, CEO, Dir | S - Sale+OE | $32.38 | -60.0K | 619.6K | -9% | -$1.94M |
| DMT | 2024-02-02 | 2024-02-01 | EQH | Pearson Mark | Pres, CEO, Dir | M - OptEx | $0.00 | -40.0K | 666.3K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | M | A | 20,052 | $21.34 | 659,677.38 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F2) Total includes Restricted Stock Units. |
| 2 | Common | Common Stock | 2024-02-01 | M | A | 19,948 | $18.74 | 679,625.38 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F2) Total includes Restricted Stock Units. |
| 3 | Common | Common Stock | 2024-02-01 | S | D | 39,600 | $32.38 | 640,025.38 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F3) This transaction was executed in multiple trades at prices ranging from $31.7700 to $32.7600. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Total includes Restricted Stock Units. |
| 4 | Common | Common Stock | 2024-02-01 | S | D | 400 | $32.80 | 639,625.38 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F4) This transaction was executed in multiple trades at prices ranging from $32.7900 to $32.8100. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Total includes Restricted Stock Units. |
| 5 | Common | Common Stock | 2024-02-01 | S | D | 20,000 | $32.38 | 619,625.38 | D | — | — | (F1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. (F5) This transaction was executed in multiple trades at prices ranging from $31.7800 to $32.7400. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Total includes Restricted Stock Units. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2024-02-01 | M | D | 19,948 | $0.00 | 646,400 | D | $18.74 · — to 2029-02-14 | 19,948 Common Stock | (F7) Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vest/vested in three installments beginning on February 14, 2020. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2024-02-01 | M | D | 20,052 | $0.00 | 666,348 | D | $21.34 · — to 2028-03-01 | 20,052 Common Stock | (F6) Grant of employee stock option under the Issuer's 2018 Omnibus Incentive Plan exempt under Rule 16b-3. The options vest/vested in three installments beginning on March 1, 2019. |